The authors of the latter study suggest that CHD4 plays a critical role in modulating cell proliferation, the HER2 signaling cascade, and autophagy, allowing speculation that CHD4 could be a target as part of treatment for HER2+ BC. This evidence concerns the gene ERBB2 and breast cancer.